Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

About

Geoffrey R Oxnard, MD, is a thoracic oncologist at Boston Medical Center (BMC), internationally recognized for both his clinical expertise in lung cancer and for his pioneering work on the use of liquid biopsies to guide the selection of targeted therapies. Dr. Oxnard sees patients one day a week at BMC, while also fulfilling his roles as researcher, associate professor of Hematology and Medical Oncology at Boston University Chobanian & Avedisian School of Medicine, and vice president and global medical lead for liquid biopsies at Foundation Medicine. Dr. Oxnard’s clinical and research interests focus on the use of diagnostics to enable precision lung cancer therapies, as well as understanding inherited lung cancer risk. After receiving his medical degree from the University of Chicago-Pritzker School of Medicine, Dr. Oxnard completed a residency in Internal Medicine at Massachusetts General Hospital and a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center.
  • Specialties

    Lung cancer

  • Administrative Title

    Associate Professor of Hematology and Medical Oncology, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Internal Medicine, Massachusetts General Hospital Residency, 2005-2008
  • Fellowship

    Hematology and Medical Oncology, Memorial Sloan Kettering Cancer Center, 2008-2011
  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

Affiliations

Affiliations